The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states
Open accessAbstract
ATP‐sensitive P2X 7 receptors are localized on cells of immunological origin including peripheral macrophages and glial cells in the CNS. Activation of P2X 7 receptors leads to rapid changes in intracellular calcium concentrations, release of the proinflammatory cytokine interleukin‐1β and following prolonged agonist exposure, the formation of cytolytic pores in plasma membranes. Both the localization and functional consequences of P2X 7 receptor activation indicate a role in inflammatory processes. The phenotype of P2X 7 receptor gene‐disrupted mice also indicates that P2X 7 receptor activation contributes to ongoing inflammation. More recently, P2X 7 receptor knockout data has also suggested a specific role in inflammatory and neuropathic pain states. The recent discovery of potent and highly selective antagonists for P2X 7 receptors has helped to further clarify P2X receptor pharmacology, expanded understanding of P2X 7 receptor signaling, and offers new evidence that P2X 7 receptors play a specific role in nociceptive signaling in chronic pain states. In this review, we incorporate the recent discoveries of novel P2X 7 receptor‐selective antagonists with a brief update on P2X 7 receptor pharmacology and its therapeutic potential. British Journal of Pharmacology (2007) 151, 571–579; doi:10.1038/sj.bjp.0707265
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739
The p38 signal transduction pathway Activation and function
Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury
Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M. W., & Inoue, K. (2003) · Nature · doi:10.1038/nature01786 · Cited by 1,563
Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrin, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,431
Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S., Allchorne, A., Poole, S., Bonventre, J. V., & Woolf, C. J. (2001) · Nature · doi:10.1038/35068566 · Cited by 1,281
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025 · cited 9×
“Other recent reviews by Fields and Burnstock (2006), Ferrari et al. (2006), Gever et al. (2006) and Khakh and North (2006) provide extensive overviews of P2X receptor physiology and pharmacology.”
BackgroundInfluentialAltered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J., Perregaux, D. G., Stam, E., Petrushova, N., Koller, B. H., Griffiths, R. J., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 930
Rapid Secretion of Interleukin-1β by Microvesicle Shedding
MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., & Surprenant, A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00229-1 · Cited by 863
Purinergic signalling in neuron–glia interactions
Fields, R. D., & Burnstock, G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1928 · Cited by 857
P2X receptors as cell-surface ATP sensors in health and disease
Khakh, B. S., & Alan North, R. (2006) · Nature · doi:10.1038/nature04886 · Cited by 856
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., Richardson, J., Peck, W. L., et al. (2005) · Pain · doi:10.1016/j.pain.2005.01.002 · Cited by 789
Perregaux, D., & Gabel, C. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36591-2 · Cited by 758
Horai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T., Asano, M., & Iwakura, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.313 · Cited by 749
Woolf, C. J., Allchorne, A., Safieh‐Garabedian, B., & Poole, S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701148 · Cited by 675
Pathophysiology and Therapeutic Potential of Purinergic Signaling
Burnstock, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.5 · Cited by 611
Safieh‐Garabedian, B., Poole, S., Allchorne, A., Winter, J., & Woolf, C. J. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15035.x · Cited by 595
Tominaga, M., Wada, M., & Masu, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111025298 · Cited by 509
Tissue distribution of the P2X7 receptor
Collo, G., Neidhart, S., Kawashima, E., Kosco-Vilbois, M., North, R. A., & Buell, G. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00140-8 · Cited by 493
Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response
Labasi, J. M., Petrushova, N., Donovan, C., McCurdy, S., Lira, P., Payette, M. M., Brissette, W., Wicks, J. R., Audoly, L., & Gabel, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6436 · Cited by 490
Parvathenani, L. K., Tertyshnikova, S., Greco, C. R., Roberts, S. B., Robertson, B., & Posmantur, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209478200 · Cited by 488
The Permeabilizing ATP Receptor, P2X7
Rassendren, F., Buell, G. N., Virginio, C., Collo, G., North, R. A., & Surprenant, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5482 · Cited by 478
Jarvis, M. F., Burgard, E. C., McGaraughty, S., Honore, P., Lynch, K., Brennan, T. J., Subieta, A., van Biesen, T., Cartmell, J., Bianchi, B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252537299 · Cited by 470
Self-citationPannexin1 is part of the pore forming unit of the P2X7 receptor death complex
Locovei, S., Scemes, E., Qiu, F., Spray, D. C., & Dahl, G. (2007) · FEBS Letters · doi:10.1016/j.febslet.2006.12.056 · Cited by 434
Elssner, A., Duncan, M., Gavrilin, M., & Wewers, M. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4987 · Cited by 425
Honore, P., Donnelly-Roberts, D., Namovic, M. T., Hsieh, G., Zhu, C. Z., Mikusa, J. P., Hernandez, G., Zhong, C., Gauvin, D. M., Chandran, P., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111559 · Cited by 414
Self-citationPore dilation of neuronal P2X receptor channels
Virginio, C., MacKenzie, A., Rassendren, F. A., North, R. A., & Surprenant, A. (1999) · Nature Neuroscience · doi:10.1038/7225 · Cited by 413
Brilliant Blue G Selectively Blocks ATP-Gated Rat P2X7Receptors
Jiang, L.-H., Mackenzie, A. B., North, R. A., & Surprenant, A. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.1.82 · Cited by 401
Proteomic and functional evidence for a P2X7 receptor signalling complex
Kim, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6347 · Cited by 379
Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor.
Murgia, M., Hanau, S., Pizzo, P., Rippa, M., & Di Virgilio, F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53082-9 · Cited by 367
Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds
Khakh, B. S., Bao, X. R., Labarca, C., & Lester, H. A. (1999) · Nature Neuroscience · doi:10.1038/7233 · Cited by 365
Purine and Pyrimidine (P2) Receptors as Drug Targets
Jacobson, K. A., Jarvis, M. F., & Williams, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020046y · Cited by 352
Self-citationMouse microglial cells express a plasma membrane pore gated by extracellular ATP
Ferrari, D., Villalba, M., Chiozzi, P., Falzoni, S., Ricciardi-Castagnoli, P., & Di Virgilio, F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1531 · Cited by 352
Virginio, C., MacKenzie, A., North, R. A., & Surprenant, A. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0335m.x · Cited by 345
Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release
Kahlenberg, J. M., & Dubyak, G. R. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00494.2003 · Cited by 337
Pharmacological characterization of recombinant human and rat P2X receptor subtypes
Bianchi, B. R., Lynch, K. J., Touma, E., Niforatos, W., Burgard, E. C., Alexander, K. M., Park, H. S., Yu, H., Metzger, R., Kowaluk, E., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00350-7 · Cited by 331
Self-citationEvans, R. J., Lewis, C., Buell, G., Valera, S., North, R. A., & Surprenant, A. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10232-0 · Cited by 316
Gever, J. R., Cockayne, D. A., Dillon, M. P., Burnstock, G., & Ford, A. P. D. W. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0070-9 · Cited by 298
Ferrari, D., Wesselborg, S., Bauer, M. K. A., & Schulze-Osthoff, K. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1635 · Cited by 286
Kinetics and Mechanism of ATP-Dependent IL-1β Release from Microglial Cells
Sanz, J. M., & Virgilio, F. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4893 · Cited by 273
Cell-Cell Communication Beyond Connexins: The Pannexin Channels
Barbe, M. T., Monyer, H., & Bruzzone, R. (2006) · Physiology · doi:10.1152/physiol.00048.2005 · Cited by 270
Reanalysis of P2X7Receptor Expression in Rodent Brain
Sim, J. A., Young, M. T., Sung, H.-Y., North, R. A., & Surprenant, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-04.2004 · Cited by 264
ATP Acts as an Agonist to Promote Stimulus-Induced Secretion of IL-1β and IL-18 in Human Blood
Perregaux, D. G., McNiff, P., Laliberte, R., Conklyn, M., & Gabel, C. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4615 · Cited by 255
Panenka, W., Jijon, H., Herx, L. M., Armstrong, J. N., Feighan, D., Wei, T., Yong, V. W., Ransohoff, R. M., & MacVicar, B. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07135.2001 · Cited by 233
Nelson, D. W., Gregg, R. J., Kort, M. E., Perez-Medrano, A., Voight, E. A., Wang, Y., Grayson, G., Namovic, M. T., Donnelly-Roberts, D. L., Niforatos, W., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051202e · Cited by 233
Self-citationHumphreys, B. D., Virginio, C., Surprenant, A., Rice, J., & Dubyak, G. R. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.22 · Cited by 215
Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin
Maier, S. F., Wiertelak, E. P., Martin, D., & Watkins, L. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91446-y · Cited by 210
Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons
Anderson, C. M., & Nedergaard, M. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.03.003 · Cited by 207
Identification of amino acid residues contributing to the pore of a P2X receptor
Rassendren, F. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3446 · Cited by 207
Gu, B. J., Zhang, W. Y., Bendall, L. J., Chessell, I. P., Buell, G. N., & Wiley, J. S. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.4.c1189 · Cited by 204
A Polymorphism in the P2X 7 Gene Increases Susceptibility to Extrapulmonary Tuberculosis
Fernando, S. L., Saunders, B. M., Sluyter, R., Skarratt, K. K., Goldberg, H., Marks, G. B., Wiley, J. S., & Britton, W. J. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-970oc · Cited by 203
The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytes
Gargett, C. E., & Wiley, J. S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701081 · Cited by 190
Humphreys, B. D., & Dubyak, G. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5627 · Cited by 188
P2X7 Receptors in Müller Glial Cells from the Human Retina
Pannicke, T., Fischer, W., Biedermann, B., Schädlich, H., Grosche, J., Faude, F., Wiedemann, P., Allgaier, C., Illes, P., Burnstock, G., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-05965.2000 · Cited by 185
Sommer, C., Petrausch, S., Lindenlaub, T., & Toyka, K. V. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00450-4 · Cited by 183
Denlinger, L. C., Fisette, P. L., Sommer, J. A., Watters, J. J., Prabhu, U., Dubyak, G. R., Proctor, R. A., & Bertics, P. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1871 · Cited by 181
Verhoef, P. A., Estacion, M., Schilling, W., & Dubyak, G. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5728 · Cited by 173
An Ile-568 to Asn Polymorphism Prevents Normal Trafficking and Function of the Human P2X7 Receptor
Wiley, J. S., Dao-Ung, L.-P., Li, C., Shemon, A. N., Gu, B. J., Smart, M. L., Fuller, S. J., Barden, J. A., Petrou, S., & Sluyter, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212759200 · Cited by 166
Wiley, J. S., Dao-Ung, L. P., Gu, B. J., Sluyter, R., Shemon, A. N., Li, C., Taper, J., Gallo, J., & Manoharan, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08156-4 · Cited by 166
Cabrini, G., Falzoni, S., Forchap, S. L., Pellegatti, P., Balboni, A., Agostini, P., Cuneo, A., Castoldi, G., Baricordi, O. R., & Di Virgilio, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.82 · Cited by 163
Chakfe, Y., Seguin, R., Antel, J. P., Morissette, C., Malo, D., Henderson, D., & Séguéla, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03061.2002 · Cited by 158
Pharmacological characterization of ATP‐ and LPS‐induced IL‐1β release in human monocytes
Grahames, C., Michel, A. D., Chessell, I. P., & Humphrey, P. P. A. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702732 · Cited by 151
Egan, T. M., Samways, D. S. K., & Li, Z. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0078-1 · Cited by 151
Touzani, O., Boutin, H., Feuvre, R. A. L., Parker, L. C., Miller, A. J., Luheshi, G. N., & Rothwell, N. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00038.2002 · Cited by 141
Characterization of a selective and potent antagonist of human P2X7receptors, AZ11645373
Stokes, L., Jiang, L., Alcaraz, L., Bent, J., Bowers, K., Fagura, M., Furber, M., Mortimore, M., Lawson, M., Theaker, J., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706933 · Cited by 138
Armstrong, J. N., Brust, T., Lewis, R. G., & MacVicar, B. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05938.2002 · Cited by 137
Jiang, L., Rassendren, F., Mackenzie, A. B., Zhang, Y.-H., Surprenant, A., & North, R. A. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00253.2005 · Cited by 132
Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists
Baxter, A., Bent, J., Bowers, K. C., Braddock, M., Brough, S., Fagura, M., Lawson, M., McInally, T., Mortimore, M., Robertson, M. J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.034 · Cited by 124
Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor‐independent mechanisms
Beigi, R. D., Kertesy, S. B., Aquilina, G. R., & Dubyak, G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705470 · Cited by 121
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain
Jarvis, M. F. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.4.513 · Cited by 120
Self-citationHonoré, P. H., WADE, C., ZHONG, C., HARRIS, R., WU, C., Ghayur, T., Iwakura, Y., Decker, M. W., Faltynek, C. R., SULLIVAN, J., et al. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.09.024 · Cited by 119
Self-citationSikora, A. G., Liu, J., Brosnan, C. F., Buell, G. N., Chessel, I., & Bloom, B. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.558 · Cited by 119
DellʼAntonio, G., Quattrini, A., Cin, E. D., Fulgenzi, A., & Ferrero, M. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10678 · Cited by 118
Donnelly‐Roberts, D. L., Namovic, M. T., Faltynek, C. R., & Jarvis, M. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059600 · Cited by 118
Self-citationAre second messengers crucial for opening the pore associated with P2X7 receptor?
Faria, R. X., DeFarias, F. P., & Alves, L. A. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00215.2004 · Cited by 118
Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells
Gendron, F., Neary, J. T., Theiss, P. M., Sun, G. Y., Gonzalez, F. A., & Weisman, G. A. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00286.2002 · Cited by 112
Adinolfi, E., Kim, M., Young, M. T., Virgilio, F. D., & Surprenant, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301508200 · Cited by 106
BRADFORD, M. D., & Soltoff, S. P. (2002) · Biochemical Journal · doi:10.1042/bj20020358 · Cited by 101
Functional expression of P2X7 receptors in non-neuronal cells of rat dorsal root ganglia
Zhang, X.-F., Han, P., Faltynek, C. R., Jarvis, M. F., & Shieh, C. (2005) · Brain Research · doi:10.1016/j.brainres.2005.06.022 · Cited by 89
Self-citationWolf, G., Yirmiya, R., Goshen, I., Iverfeldt, K., Holmlund, L., Takeda, K., & Shavit, Y. (2003) · Pain · doi:10.1016/s0304-3959(03)00067-8 · Cited by 89
Antinociceptive effect of a new P2Z/P2X7 antagonist, oxidized ATP, in arthritic rats
DellʼAntonio, G., Quattrini, A., Cin, E. D., Fulgenzi, A., & Ferrero, M. E. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00385-3 · Cited by 86
Aga, M., Johnson, C. J., Hart, A. P., Guadarrama, A. G., Suresh, M., Svaren, J. P., Bertics, P. J., & Darien, B. J. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.1.222 · Cited by 75
Schilling, W. P., Sinkins, W. G., & Estación, M. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.4.c755 · Cited by 72
Virgilio, F. D. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705469 · Cited by 70
Inoue, K., Tsuda, M., & Koizumi, S. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.94.112 · Cited by 69
Co-activation of P2Y2 Receptor and TRPV Channel by ATP: Implications for ATP Induced Pain
Lakshmi, S., & Joshi, P. G. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-005-4936-8 · Cited by 66
Novel P2X7 receptor antagonists
Alcaraz, L., Baxter, A., Bent, J., Bowers, K. C., Braddock, M., Cladingboel, D. E., Donald, D. K., Fagura, M., Furber, M., Laurent, C., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.033 · Cited by 59
Interleukin-1 and nociception in the rat
Bianchi, M., Dib, B., & Panerai, A. E. (1998) · Journal of Neuroscience Research · Cited by 53
Michel, A. D., Xing, M., Thompson, K. M., Jones, C. A., & Humphrey, P. P. A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.01.009 · Cited by 46
da Cruz, C. M., Ventura, A. L. M., Schachter, J., Costa‐Junior, H. M., Souza, H. A. D. S., Gomes, F. R., Coutinho‐Silva, R., Ojcius, D. M., & Persechini, P. M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706559 · Cited by 38
Michel, A. D., Thompson, K. M., Simon, J., Boyfield, I., Fonfría, E., & Humphrey, P. P. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706938 · Cited by 29
Carter, A. B., Tephly, L. A., & Hunninghake, G. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100209200 · Cited by 27
Dynamics of P2X7 receptor pore dilation: Pharmacological and functional consequences
Chessell, I. P., Grahames, C., Michel, A. D., & Humphrey, P. P. A. (2001) · Drug Development Research · doi:10.1002/ddr.1171 · Cited by 19
Interleukin‐1β posttranslational processing—exploration of P2X7 receptor involvement
Perregaux, D. G., Labasi, J. M., Laliberte, R., Stam, E. J., Solle, M., Koller, B. H., Griffiths, R., & Gabel, C. A. (2001) · Drug Development Research · doi:10.1002/ddr.1175 · Cited by 5
Cited by
The neuropathic pain triad: neurons, immune cells and glia
Scholz, J., & Woolf, C. J. (2007) · Nature Neuroscience · doi:10.1038/nn1992 · Cited by 1,732
Purinergic signalling and disorders of the central nervous system
Burnstock, G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2605 · Cited by 634
Signaling at Purinergic P2X Receptors
Surprenant, A., & North, R. A. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100630 · Cited by 547
Purinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illes, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 397
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 393
Metadata
- Authors
- Donnelly‐Roberts, D. L., & Jarvis, M. F.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-07
- Volume
- 151
- Issue
- 5
- Pages
- 571-579
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2034182613
- Cited by
- 266
- References
- 94
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.